MTI Ltd. (JP:9438) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
MTI Ltd. has revised its full-year consolidated financial forecasts upward, thanks to stronger-than-expected sales in its cloud drug record and corporate DX Support businesses. The updated forecast anticipates increases in net sales, operating income, ordinary income, and profit attributable to owners of the parent, with significant percentage increases in operating income and profits. These optimistic revisions are also influenced by extraordinary income from equity investments and tax refunds from subsidiary companies.
For further insights into JP:9438 stock, check out TipRanks’ Stock Analysis page.